Abbott LaboratoriesNYSE: ABT

Abbott Laboratories' top line was somewhat inconsistent in recent years due to swings in its COVID-related revenues. Johnson & Johnson has been restructuring, spinning off its consumer health segment and bolstering its medical device segment by acquiring Abiomed.

Investors frequently depend on analyst recommendations when choosing to buy, sell, or hold a stock. Changes in ratings from these analysts, who work for brokerage firms, can impact a stock's price, but how significant are they really?

Abbott (ABT) has recently caught the attention of many Zacks.com users. Therefore, it's important to look into what the future holds for this stock.

The ProShares S&P 500 Dividend Aristocrats ETF continues to perform well in the latter half of 2024, with a 3.69% increase in August. I will share three strategies that could potentially outperform the dividend aristocrat index over time. After monitoring these strategies for 38 months, all three have shown a higher compound annual growth rate (CAGR) than NOBL, along with a better initial dividend yield.

Abbott (ABT) finished the last trading day at $112.73, which is an increase of 0.11% compared to the day before.

To tackle the significant need for blood donations, Abbott, a leader in blood testing, is partnering with the Big Ten Conference to launch a blood donation competition among colleges. The school that collects the most donations during the 2024 football season will receive a $1 million donation from Abbott to support student or community health, announced at the Discover Big Ten Football Championship Game. Students, alumni, and fans can donate on behalf of any of the 18 member schools, with totals tracked live at BigTen.Org/Abbott, and participants will get a free month of B1G+ streaming and a chance to win tickets to the championship game.

Abbott (NYSE: ABT) will release its financial results for the third quarter of 2024 on Wednesday, October 16, before the market starts. This announcement will take place in Abbott Park, Illinois, on September 25, 2024.

This summer, the S&P 500 experienced an 8% drop over three weeks due to a market sell-off. Such downturns can occur at any point in both rising and falling markets, making it essential to be ready for them.

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, a company under Asahi Kasei that produces medical devices and software, has announced that the first patient has joined the SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE). This study aims to gather more evidence on how effective SuperSaturated Oxygen (SSO2) Therapy is in lowering heart failure and death rates in patients with left anterior descending ST-elevation myocardial infarction.